COMMON STOCK PURCHASE WARRANT AGILE THERAPEUTICS, INC.Agile Therapeutics Inc • October 8th, 2021 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from AGILE THERAPEUTICS, INC., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
26,666,648 Shares of Common Stock Warrants to Purchase up to 13,333,324 Shares of Common Stock AGILE THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 8th, 2021 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
Agile Therapeutics, Inc., a Delaware corporation (the "Company"), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the "Underwriters"), for whom you are acting as Representative (the "Representative"), an aggregate of 26,666,648 shares (the "Shares") of the Company's common stock, $0.0001 par value per share (the "Common Stock"), together with warrants to purchase an aggregate of 13,333,324 shares of Common Stock, in the form filed as an exhibit to the Registration Statement (as hereinafter defined) (the “Warrants” and collectively with the Shares, the “Securities”). The shares of Common Stock into which the Warrants are exercisable are hereinafter referred to as the “Warrant Shares.” The respective amounts of the Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. Each Share will be sold together with one-half of a Warrant
